Related Experiment Video
Updated: Jul 9, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
The malignant stroke indicator is an early indicator of malignant ischemic stroke requiring decompressive
Xenia Hautmann1,2, Ala Jamous3, Ilko Maier4
1Department of Neurosurgery, University Medical Center Göttingen, Robert-Koch Straße 40, 37075, Göttingen, Germany.
Insights
A new Malignant Stroke Indicator (MSI) score helps identify patients needing decompressive craniectomy (DHC) for malignant ischemic stroke. The MSI score accurately predicts the likelihood of requiring this life-saving intervention.
Area of Science:
- Neurology
- Neurosurgery
- Stroke Medicine
Background:
- Malignant ischemic stroke poses a significant mortality risk.
- Early identification of patients requiring decompressive craniectomy (DHC) is crucial but lacks clear criteria.
- Developing a predictive tool for DHC necessity is vital for timely intervention.
Purpose of the Study:
- To develop and validate a scoring system for predicting the need for decompressive craniectomy (DHC) in patients with ischemic stroke.
- To identify key clinical and radiological parameters associated with malignant stroke progression requiring DHC.
- To create a Malignant Stroke Indicator (MSI) score for early risk stratification.
Main Methods:
- Retrospective observational study analyzing a cohort of 534 ischemic stroke patients (2010-2021).
- Clinical and radiological parameters were assessed using univariate and multivariate regression analyses.
- A Malignant Stroke Indicator (MSI) score was constructed based on age, midline shift, recanalization status, basal cistern effacement, and CBV ASPECTS.
Main Results:
- The MSI score incorporates age < 70 years (7 pts), midline shift (≤6 pts), unsuccessful recanalization TICI < 2b (6 pts), basal cistern effacement (4 pts), and CBV ASPECTS < 6 (3 pts).
- An MSI score cutoff of 9 demonstrated high predictive power for DHC necessity (AUC 0.90, p < 0.0001).
- Patients with an MSI score ≥ 9 had a 22.9-fold increased probability of requiring DHC (p < 0.0001).
Conclusions:
- The Malignant Stroke Indicator (MSI) score is a promising tool for predicting the need for decompressive craniectomy in high-risk ischemic stroke patients.
- The MSI score facilitates early identification of individuals likely to develop malignant stroke requiring DHC.
- Further validation in external cohorts is recommended to confirm the generalizability of the MSI score.
Abstract:
Decompressive craniectomy (DHC) can prevent mortality in patients with malignant ischemic stroke. However, no clear criteria have been established to early identify patients, who will develop malignant stroke requiring DHC. In this retrospective observational study, a large patient cohort with ischemic stroke treated between 2010 and 2021, was analyzed. Clinical and radiological parameters were analyzed. Univariate and multivariate regression analyses were performed to identify the parameters to be included in the score. A cohort of 534 patients was included. A malignant stroke indicator (MSI) score was created including age < 70 years with 7 points, midline shift with up to 6 points, unsuccessful recanalization (TICI < 2b) with 6 points, basal cistern effacement with 4 points, and CBV ASPECTS < 6 with 3 points assigned. A MSI score with a cutoff value of 9 showed a high discrimination power concerning the need for DHC (AUC 0.90, p < 0.0001). Patients with MSI-score ≥ 9 had a 22-fold higher probability of needing DHC (odds ratio 22.90, p < 0.0001). The MSI score is a promising tool to predict the need for DHC in patients at risk for developing a malignant stroke and needs to be validated in external cohorts.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

